Most Read Articles
Jairia Dela Cruz, 24 Jan 2017
The likelihood of developing atopic dermatitis and food sensitization may be low among children with habitual consumption of yogurt products in infancy, according to a recent study.
12 Dec 2017
The use of oral antidepressants appears to have beneficial effects on patients with chronic pruritus not responding to topical treatment and oral antihistamines, particularly those with uremic pruritus, cholestatic pruritus or paraneoplastic pruritus, according to a recent study.
Gayle Fischer, 01 Jun 2014

Acute vulvovaginal candidiasis (VVC) is common and usually easily treated but some women develop chronic symptoms that do not respond to conventional anti-Candida treatment. Recently proposed diagnostic criteria may help clinicians identify women with chronic VVC. Evidence is mounting that it represents a hypersensitivity response to commensal Candida spp. It usually responds to long-term antifungal treatment.

21 Dec 2017
Speedy treatment of stage I melanoma is likely to result in improved outcomes, suggests a recent study.

Quality of life, sexual function lower in patients with hidradenitis suppurativa

6 days ago
Regular sexual intercourse is linked to a variety of physical and psychological health boosts

Hidradenitis suppurativa (HS) disrupts sexual function, which exerts a strong negative effect on quality of life (QoL) index scores, regardless of genital lesions, a recent study has shown.

The researchers performed a cross-sectional observational study on 50 HS patients to whom QoL and sexual functioning questionnaires were administered. A parallel group of 50 healthy controls was also included.

Compared with the control group, Dermatology Life Quality Index (DLQI) scores were significantly lower in the HS group (p<0.0001), indicating worse QoL.

Analysis by sex showed that males with HS had significantly lower scores in the Sexual Quality of Life Questionnaire for Use in Men (SQoLM; p<0.0001) and International Index of Erectile Dysfunction (IIEF; p=0.019) relative to controls.

In comparison, distress related to sexual function, as measured by the revised Female Sexual Distress Scale (FSD-R), was significantly higher in females with vs without HS (p=0.002). HS did not lead to significant changes in Female Sexual Function Index scores (p=0.075).

Scores in the SQoLM (p=0.001) and FSDR (p<0.001) were significantly associated with the extent of sexual difficulties caused by the skin.

Notably, the presence of genital lesions did not cause significant changes in DLQI scores or sexual function measures in both males and females.

In hierarchical regression analyses, scores in the SQoLM and IIEF explained 72 percent of the variation in DLQI scores in males. Similarly, majority of the variance in female QoL scores was also explained by sexual distress and dysfunction.

“Overall, these results show that both male and female patients with HS experienced a negative impact on QoL and that sexual dysfunction is an important contributor to this impaired QoL,” said researchers.

Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 24 Jan 2017
The likelihood of developing atopic dermatitis and food sensitization may be low among children with habitual consumption of yogurt products in infancy, according to a recent study.
12 Dec 2017
The use of oral antidepressants appears to have beneficial effects on patients with chronic pruritus not responding to topical treatment and oral antihistamines, particularly those with uremic pruritus, cholestatic pruritus or paraneoplastic pruritus, according to a recent study.
Gayle Fischer, 01 Jun 2014

Acute vulvovaginal candidiasis (VVC) is common and usually easily treated but some women develop chronic symptoms that do not respond to conventional anti-Candida treatment. Recently proposed diagnostic criteria may help clinicians identify women with chronic VVC. Evidence is mounting that it represents a hypersensitivity response to commensal Candida spp. It usually responds to long-term antifungal treatment.

21 Dec 2017
Speedy treatment of stage I melanoma is likely to result in improved outcomes, suggests a recent study.